Clinics in liver disease, 2018-02, Vol.22 (1), p.213-227
2018
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
- Ist Teil von
- Clinics in liver disease, 2018-02, Vol.22 (1), p.213-227
- Ort / Verlag
- United States: Elsevier Inc
- Erscheinungsjahr
- 2018
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- The number of transplants caused by nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NASH) has been progressively increasing and this is expected to become the most common indication for liver transplant in the United States. Patients with NASH show many features of the metabolic syndrome and, as a result, are at higher risk for postoperative cardiovascular morbidity and mortality. Despite this, patients with NASH have long-term graft and patient survival rates comparable with other causes of chronic liver disease. Posttransplant metabolic syndrome is a common occurrence that increases the risk of steatosis in the graft liver.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1089-3261eISSN: 1557-8224DOI: 10.1016/j.cld.2017.08.015Titel-ID: cdi_pubmed_primary_29128058
- Format
- –
- Schlagworte
- Cardiovascular Diseases - complications, Diabetes Complications - complications, Humans, Kidney Diseases - complications, Lipase - genetics, Liver transplant, Liver Transplantation - adverse effects, Membrane Proteins - genetics, Metabolic syndrome, Metabolic Syndrome - etiology, Mutation, Non-alcoholic Fatty Liver Disease - complications, Non-alcoholic Fatty Liver Disease - genetics, Non-alcoholic Fatty Liver Disease - surgery, Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Obesity - complications, Postoperative Complications - etiology, Preoperative Period, Recurrent NAFLD